OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 9-19
Open Access | Times Cited: 10
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 9-19
Open Access | Times Cited: 10
Showing 10 citing articles:
Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management
Kit‐Leong Cheong, Shutong Chen, Bo Teng, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 860-860
Open Access | Times Cited: 14
Kit‐Leong Cheong, Shutong Chen, Bo Teng, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 860-860
Open Access | Times Cited: 14
Metabolic Profiling Reveals Potential Prognostic Biomarkers for SFTS: Insights into Disease Severity and Clinical Outcomes
Zhuo-Min Zhu, Huan-Yu Liu, Na An, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 228-228
Open Access
Zhuo-Min Zhu, Huan-Yu Liu, Na An, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 228-228
Open Access
Dantrolene and ryanodine receptors in COVID ‐19: The daunting task and neglected warden
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 11
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 11
Ursodeoxycholic acid relieves clinical severity of COVID-19 in patients with chronic liver diseases
Tiantian Hu, Jie Tong, Yunhui Yang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Tiantian Hu, Jie Tong, Yunhui Yang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Oral Bemnifosbuvir (AT-527) Vs Placebo in Patients With mild-to-moderate COVID-19 in an Outpatient Setting (MORNINGSKY)
Arantxa Horga, Rebecca Saenz, Gürdal Yılmaz, et al.
Future Virology (2023) Vol. 18, Iss. 13, pp. 839-853
Open Access | Times Cited: 9
Arantxa Horga, Rebecca Saenz, Gürdal Yılmaz, et al.
Future Virology (2023) Vol. 18, Iss. 13, pp. 839-853
Open Access | Times Cited: 9
Bile acids and coronavirus disease 2019
Xiaoru Huang, Xuening Liu, Zijian Li
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1939-1950
Open Access | Times Cited: 3
Xiaoru Huang, Xuening Liu, Zijian Li
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1939-1950
Open Access | Times Cited: 3
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 8
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 8
Bioactivities, Mechanisms, Production, and Potential Application of Bile Acids in Preventing and Treating Infectious Diseases
Shuang Liu, Shuo Yang, Biljana Blažeković, et al.
Engineering (2024) Vol. 38, pp. 13-26
Open Access | Times Cited: 1
Shuang Liu, Shuo Yang, Biljana Blažeković, et al.
Engineering (2024) Vol. 38, pp. 13-26
Open Access | Times Cited: 1
Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2
Sumera Zaib, Nehal Rana, Hafiz Saqib Ali, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127379-127379
Closed Access | Times Cited: 3
Sumera Zaib, Nehal Rana, Hafiz Saqib Ali, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127379-127379
Closed Access | Times Cited: 3
Can Ursodeoxycholic Acid Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Reduce the Coronavirus Disease 2019 Severity? Current Knowledge and Unresolved Issues
Shida Pan, Yang Zhang, Fanping Meng, et al.
Infectious Diseases & Immunity (2023)
Open Access
Shida Pan, Yang Zhang, Fanping Meng, et al.
Infectious Diseases & Immunity (2023)
Open Access
